They found that those that received PII had improved insulin action, while those who received a stable insulin infusion or reduced amplitude pulses of insulin (as seen in Type 2 Diabetes) had abnormal liver metabolism resulting in increased liver production of glucose and worsening hyperglycemia with insulin resistance. The gene discussed is INS; the disease is Hyperglycemia.